介入性影像市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按产品、按应用、地区和竞争细分

2022 年，全球介入影像市场价值为 238.7 亿美元，预计到 2028 年，预测期内将出现强劲成长，复合CAGR为 5.35%。介入影像透过提供即时影像引导程序，彻底改变了医疗领域确保高精确度并大幅改善患者的治疗效果。这些尖端技术改变了医疗专业人员诊断和治疗各种疾病的方式，从复杂的手术到微创手术。

这种强劲的成长可归因于多种因素。首先，全球癌症发生率的上升扩大了对介入影像的需求，提供精确的诊断和治疗解决方案，有助于早期发现和有效治疗。可视化肿瘤并透过治疗干预精确瞄准肿瘤的能力显着提高了患者的生存率。

此外，政府和医疗保健组织的意识计划和倡议在阐明介入成像技术的优势方面发挥了至关重要的作用。这些倡议帮助医疗保健专业人员和患者了解这些先进技术的潜力，从而使其广泛采用并融入标准医疗实践。

市场概况
预测期	2024-2028
2022 年市场规模	238.7亿美元
2028 年市场规模	323.9亿美元
2023-2028 年CAGR	5.35%
成长最快的细分市场	亚太地区
最大的市场	北美洲

技术进步是市场扩张的另一个关键驱动力。介入影像领域的持续研究和开发活动带来了更先进、更有效率的影像系统。高解析度影像、即时视觉化和改进的影像引导功能等创新彻底改变了介入手术的精确度和准确性，进一步改善了患者的治疗效果。

目录

第 1 章：产品概述

• 市场定义
• 市场范围
  • 涵盖的市场
  • 考虑学习的年份
  • 主要市场区隔

第 2 章：研究方法

• 研究目的
• 基线方法
• 主要产业伙伴
• 主要关联和次要应用
• 预测方法
• 数据三角测量与验证
• 假设和限制

第 3 章：执行摘要

• 市场概况
• 主要市场细分概述
• 主要市场参与者概述
• 重点地区/国家概况
• 市场驱动因素、挑战、趋势概述

第 4 章：COVID-19 对全球介入性影像市场的影响

第 5 章：全球介入影像市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依产品提供（CT 扫描仪、X 光系统、MRI 系统、超音波影像系统等）
  • 按应用（心臟、神经学、肌肉骨骼学、肿瘤学、泌尿科、胃肠病学、产科、妇科、其他）
  • 按地区
  • 按公司划分 (2022)
• 市场地图

第 6 章：亚太介入影像市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 透过提供
  • 按应用
  • 按国家/地区
• 亚太地区：国家分析
  • 中国介入影像
  • 印度介入影像
  • 澳洲介入影像
  • 日本介入影像
  • 韩国介入影像

第 7 章：欧洲介入影像市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 透过提供
  • 按应用
  • 按国家/地区
• 欧洲：国家分析
  • 法国
  • 德国
  • 西班牙
  • 义大利
  • 英国

第 8 章：北美介入影像市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 透过提供
  • 按应用
  • 按国家/地区
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第 9 章：南美洲介入影像市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 透过提供
  • 按应用
  • 按国家/地区
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第10章：中东和非洲介入影像市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 透过提供
  • 按应用
  • 按国家/地区
• MEA：国家分析
  • 南非介入影像
  • 沙乌地阿拉伯介入影像
  • 阿联酋介入影像

第 11 章：市场动态

• 司机
• 挑战

第 12 章：市场趋势与发展

• 最近的发展
• 产品发布
• 併购

第 13 章：全球介入性影像市场：SWOT 分析

第 14 章：波特的五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 客户的力量
• 替代产品的威胁

第 15 章：大环境分析

第 16 章：定价分析

第17章：竞争格局

• 贝克顿迪金森公司
  • Business Overview
  • Company Snapshot
  • Products & Services
  • Financials (As Reported)
  • Recent Developments
• 佳能公司
• 百胜公司
• 富士胶片控股公司
• 豪洛捷公司
• 直觉外科公司
• 皇家飞利浦公司
• 美敦力公司
• 西门子医疗集团
• 史赛克公司

第 18 章：策略建议

第 19 章：关于我们与免责声明

Global Interventional Imaging Market has valued at USD23.87 billion in 2022 and is anticipated to project robust growth in the forecast period with a CAGR of 5.35% through 2028. Interventional imaging has revolutionized the medical field by providing real-time, image-guided procedures that ensure high precision and greatly improved patient outcomes. These cutting-edge techniques have transformed the way medical professionals diagnose and treat various conditions, from complex surgeries to minimally invasive procedures.

This robust growth can be attributed to various factors. Firstly, the global rise in cancer incidence has amplified the demand for interventional imaging, offering precise diagnostic and treatment solutions that aid in early detection and effective therapies. The ability to visualize tumors and precisely target them with therapeutic interventions has significantly improved patient survival rates.

Additionally, awareness programs and initiatives by government and healthcare organizations have played a crucial role in illuminating the benefits of interventional imaging technologies. These initiatives have helped educate both healthcare professionals and patients on the potential of these advanced techniques, leading to their widespread adoption and integration into standard medical practices.

Market Overview
Forecast Period	2024-2028
Market Size 2022	USD 23.87 Billion
Market Size 2028	USD 32.39 Billion
CAGR 2023-2028	5.35%
Fastest Growing Segment	Asia Pacific
Largest Market	North America

Technological advancements are another pivotal driver for the market's expansion. Continuous research and development activities in the field of interventional imaging have resulted in more advanced and efficient imaging systems. Innovations such as high-resolution imaging, real-time visualization, and improved image-guidance capabilities have revolutionized the precision and accuracy of interventional procedures, further enhancing patient outcomes.

Manufacturers in the interventional imaging industry are investing heavily in research to develop innovative products that offer them a competitive edge in the market. This focus on advancing technology has led to the introduction of state-of-the-art imaging systems with enhanced functionalities and improved user experience. These advancements not only benefit healthcare providers but also contribute to the overall growth of the market.

However, despite the remarkable progress made in interventional imaging, the market faces some challenges. The high cost of interventional imaging systems remains a significant barrier, limiting access to these advanced technologies in certain regions. Additionally, the lack of skilled professionals trained in interventional imaging techniques poses a challenge to the widespread adoption and implementation of these procedures.

Key Market Drivers

Rise in Cardiovascular and Neurovascular Interventions

Cardiovascular diseases (CVDs) are the leading cause of death globally, affecting millions of people every year. According to the World Health Organization, an estimated 17.9 million people lost their lives to CVDs in 2019 alone, accounting for a staggering 32% of all global deaths. This alarming statistic highlights the urgent need for effective solutions in the field of cardiovascular medicine.

In recent years, minimally invasive cardiovascular interventions have gained significant traction as a preferred approach for treatment. These procedures offer several advantages over traditional open surgery, including reduced risk, shorter recovery time, and improved patient outcomes. As a result, they have become increasingly prevalent in clinical practice.

One crucial aspect that underpins the success of minimally invasive cardiovascular interventions is interventional imaging technologies. These advanced imaging techniques play a pivotal role in accurate diagnosis, treatment planning, and real-time guidance during procedures. By providing high-resolution images, interventional imaging technologies enable healthcare professionals to navigate complex cardiovascular structures with precision and ensure optimal patient care.

It is not only cardiovascular conditions that benefit from minimally invasive interventions. Neurovascular conditions, such as stroke and aneurysms, also require specialized treatments. The growing prevalence of these conditions, coupled with advancements in neurovascular intervention techniques, has fueled a surge in demand for interventional imaging technologies in this field as well. For instance, endovascular coiling, a procedure used to block blood flow into an aneurysm, heavily relies on advanced imaging technologies to guide the accurate placement of the coil.

The increasing adoption of cardiovascular and neurovascular interventions has created a ripple effect that fuels the growth of the global interventional imaging market. Manufacturers in the industry are investing heavily in research and development activities to innovate and improve their offerings. This includes the development of cutting-edge 3D imaging technologies and software solutions that provide real-time, high-resolution images, further enhancing the capabilities of interventional procedures.

As the demand for cardiovascular and neurovascular interventions continues to rise, the global interventional imaging market is poised for sustained growth. Ongoing advancements in technology, coupled with the increasing preference for minimally invasive procedures, ensure that the demand for interventional imaging technologies will remain high. With a focus on innovation and a commitment to improving patient outcomes, the field of interventional imaging is set to revolutionize the way we diagnose and treat cardiovascular and neurovascular diseases.

Expansion in Oncology Applications

As the medical community relentlessly strives to combat this disease, interventional imaging has emerged as a critical and indispensable tool in the ever-evolving landscape of oncology. With its ability to provide real-time guidance for an array of minimally invasive procedures used in cancer treatment, including tumor ablation, biopsy, and targeted drug delivery, interventional imaging has revolutionized the way clinicians approach patient care.

These advanced procedures, facilitated by interventional imaging, allow for precise treatment application, minimizing damage to healthy tissue and optimizing patient outcomes. By providing clinicians with real-time images and invaluable insights, interventional imaging empowers them to perform procedures with enhanced precision and accuracy, ultimately leading to improved patient care and better long-term prognosis.

As the role of interventional imaging in oncology continues to expand, there is a corresponding increase in the demand for advanced imaging technologies. Recognizing the immense potential and benefits of these technologies, manufacturers are investing heavily in research and development to further innovate and improve their product offerings.

One area of focus in this pursuit is the development of high-resolution 3D imaging technologies and software solutions. These cutting-edge advancements enable clinicians to obtain highly detailed, three-dimensional images in real-time, providing them with a comprehensive understanding of the patient's anatomy and pathology. Armed with this level of precision and clarity, clinicians can perform procedures with even greater confidence, ensuring the best possible outcomes for their patients.

These remarkable advancements in interventional imaging are driving the growth of the global interventional imaging market. As healthcare providers and institutions increasingly recognize the immense value and transformative potential of these technologies, the demand for interventional imaging continues to surge. With ongoing research and development efforts, we can expect to see even more groundbreaking innovations in the field of interventional imaging, further revolutionizing the landscape of oncology and improving patient care worldwide.

Key Market Challenges

Growing Concerns About Infection Control

Healthcare-associated infections (HAIs) pose a severe risk to patients, and interventional radiology is not immune to this phenomenon. The use of imaging equipment across multiple patients increases the potential for cross-contamination if proper infection prevention and control (IPC) practices are not followed.

In recent times, concerns about infection control in interventional imaging have heightened. Radiology departments must now adhere to strict IPC practices to prevent and control the spread of pathogens. This includes measures such as thorough disinfection of equipment, proper hand hygiene, and the use of personal protective equipment (PPE) by healthcare professionals.

Despite these measures, the challenge persists, necessitating a more comprehensive approach to infection control in interventional imaging. This could involve implementing advanced technologies such as antimicrobial coatings on equipment surfaces, utilizing air filtration systems, and employing innovative sterilization methods.

The growing concerns around infection control can potentially impact the global interventional imaging market. For one, it can increase operational costs as healthcare facilities invest in rigorous IPC practices. This could include the cost of training staff on infection control protocols, implementing standardized guidelines, and investing in single-use or easier-to-clean equipment.

Furthermore, any lapses in infection control could lead to patient harm, resulting in reputational damage and potential legal consequences for healthcare providers. This could indirectly affect the interventional imaging market by reducing trust in these procedures and impacting demand. Therefore, healthcare facilities and manufacturers must prioritize infection control efforts to ensure patient safety and maintain the integrity of interventional imaging practices.

Key Market Trends

Growing Focus on Patient Safety and Radiation Dose Reduction

Patient safety is of utmost importance in any medical procedure, and this holds true for interventional imaging as well. These minimally invasive procedures, while providing several benefits, do carry potential risks. These risks include exposure to radiation, complications arising from contrast agents, and procedural complications.

In recent years, there has been a notable shift towards enhancing patient safety in the field of interventional imaging. This shift encompasses various aspects, such as improved training for medical personnel, the development of comprehensive guidelines and protocols to minimize risks, and the integration of technological advancements to bolster the safety and efficacy of procedures.

Interventional imaging procedures often involve the use of ionizing radiation, which can pose a risk to both patients and healthcare workers. Overexposure to radiation can result in tissue damage and increase the likelihood of developing cancer.

As a consequence, there is a growing emphasis on reducing radiation doses in interventional imaging. This reduction is achieved through a combination of technological advancements, modifications to procedural techniques, and the implementation of enhanced radiation safety protocols. For instance, many newly developed imaging systems now incorporate features that automatically adjust radiation doses, ensuring that only the minimum necessary dose is utilized.

The focus on patient safety and radiation dose reduction has had a significant impact on the global interventional imaging market. It has driven innovation, prompting manufacturers to heavily invest in research and development to create safer and more effective imaging technologies.

Healthcare providers are influenced by this trend when making purchasing decisions, showing a preference for systems that prioritize patient safety and dose reduction. Additionally, this focus on safety has also shaped training programs and procedural protocols, placing a greater emphasis on radiation safety measures.

Segmental Insights

Offering Insights

Based on the category of offering, the CT scanners segment emerged as the dominant player in the global market for interventional imaging in 2022. Technological advancements have revolutionized the field of medical imaging, and CT scanners have emerged as a crucial component in diagnostic procedures. With continuous improvements in resolution, speed, and software, CT scans have become more accurate and efficient, facilitating precise patient diagnosis and treatment planning.

In recent years, the development of mobile CT scanners has further broadened their applications, making them accessible in various healthcare settings, including global medical missions. These portable scanners bring diagnostic capabilities to underserved areas, allowing healthcare professionals to reach patients in remote locations and provide timely and accurate diagnoses.

As patients become increasingly aware of the benefits of CT technology, the demand for CT imaging has surged. This demand stems from the desire for less invasive diagnostic strategies, and CT scanners effectively fulfill this need. By capturing detailed images of body structures, CT scans enable healthcare providers to comprehensive obtain a comprehensive view of the patient's condition, facilitating accurate disease diagnosis and management.

Application Insights

The cardiology industry segment is projected to experience rapid growth during the forecast period. One of the primary reasons for cardiology's dominance in the interventional imaging market is the increasing prevalence of cardiovascular diseases worldwide. With the rising numbers of individuals affected by these conditions, there is a growing demand for diagnostic and interventional procedures that utilize advanced imaging technologies. Interventional cardiology devices, including cardiac CT scanners, play a crucial role in accurately diagnosing and effectively managing these cardiovascular conditions.

Furthermore, the continuous technological advancements in interventional cardiology have significantly contributed to its market dominance. The development of more precise and efficient devices has greatly improved the efficacy of cardiac interventions, leading to their widespread adoption across the healthcare sector. These advancements empower healthcare professionals to provide more targeted and successful treatments, ultimately enhancing patient outcomes.

Moreover, it's important to highlight that favorable reimbursement policies for interventional cardiology procedures in certain regions have further fueled the growth of this sector. These policies create a financially viable environment for healthcare providers to offer these interventions, leading to an increased prevalence of interventional cardiology services. As a result, more individuals can access and benefit from these life-saving procedures, contributing to overall improvements in public health.

Regional Insights

North America emerged as the dominant player in the Global Interventional Imaging Market in 2022, holding the largest market share in terms of value. One of the primary reasons for North America's dominance in the market is the high prevalence of chronic diseases. These conditions, such as cardiovascular diseases, cancer, and respiratory disorders, often require diagnostic and interventional procedures that utilize advanced imaging technologies. This includes techniques like computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound, which play a crucial role in accurate diagnosis and treatment planning.

In addition to the high prevalence of chronic diseases, the growing geriatric population in North America is another significant factor contributing to the demand for interventional imaging procedures. As the population ages, the incidence of age-related health conditions, such as cardiovascular diseases, osteoarthritis, and neurodegenerative disorders, increases. These conditions often require minimally invasive interventions, such as angioplasty, joint injections, and America's neurointerventions, which rely on interventional radiology techniques for precise diagnosis and treatment.

Furthermore, North America's quick adoption of interventional radiology products can be attributed to the region's advanced healthcare infrastructure and substantial healthcare expenditures. The availability of state-of-the-art medical facilities, well-equipped hospitals, and skilled healthcare professionals enables the seamless integration of innovative interventional radiology technologies. This, in turn, enhances patient care, improves treatment outcomes, and drives the growth of the interventional radiology market in North America.

Key Market Players

Becton, Dickinson and Company

Canon Inc.

Esaote SpA

FUJIFILM Holdings Corporation

Hologic, Inc.

Intuitive Surgical, Inc.

Koninklijke Philips NV

Medtronic plc

Siemens Healthineers AG

Stryker Corporation

Report Scope:

In this report, the Global Interventional Imaging Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Interventional Imaging Market, By Offering:

• CT Scanners
• X-Ray Systems
• MRI Systems
• Ultrasound Imaging Systems
• Others

Interventional Imaging Market, By Application:

• Cardiology
• Neurology
• Musculoskeletal
• Oncology
• Urology
• Gastroenterology
• Obstetrics
• Gynecology
• Others

Interventional Imaging Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait
• Turkey
• Egypt

Competitive Landscape

• Company Profiles: Detailed analysis of the major companies present in the Global Interventional Imaging Market.

Available Customizations:

• Global Interventional Imaging Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Applications
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Impact of COVID-19 on Global Interventional Imaging Market

5. Global Interventional Imaging Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Offering (CT Scanners, X-Ray Systems, MRI Systems, Ultrasound Imaging Systems, Others)
  • 5.2.2. By Application (Cardiology, Neurology, Musculoskeletal, Oncology, Urology, Gastroenterology, Obstetrics, Gynecology, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2022)
• 5.3. Market Map

6. Asia Pacific Interventional Imaging Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Offering
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. Asia Pacific: Country Analysis
  • 6.3.1. China Interventional Imaging Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Offering
      • 6.3.1.2.2. By Application
  • 6.3.2. India Interventional Imaging Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Offering
      • 6.3.2.2.2. By Application
  • 6.3.3. Australia Interventional Imaging Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Offering
      • 6.3.3.2.2. By Application
  • 6.3.4. Japan Interventional Imaging Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Offering
      • 6.3.4.2.2. By Application
  • 6.3.5. South Korea Interventional Imaging Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Offering
      • 6.3.5.2.2. By Application

7. Europe Interventional Imaging Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Offering
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Interventional Imaging Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Offering
      • 7.3.1.2.2. By Application
  • 7.3.2. Germany Interventional Imaging Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Offering
      • 7.3.2.2.2. By Application
  • 7.3.3. Spain Interventional Imaging Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Offering
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Interventional Imaging Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Offering
      • 7.3.4.2.2. By Application
  • 7.3.5. United Kingdom Interventional Imaging Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Offering
      • 7.3.5.2.2. By Application

8. North America Interventional Imaging Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Offering
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. North America: Country Analysis
  • 8.3.1. United States Interventional Imaging Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Offering
      • 8.3.1.2.2. By Application
  • 8.3.2. Mexico Interventional Imaging Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Offering
      • 8.3.2.2.2. By Application
  • 8.3.3. Canada Interventional Imaging Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Offering
      • 8.3.3.2.2. By Application

9. South America Interventional Imaging Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Offering
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Interventional Imaging Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Offering
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Interventional Imaging Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Offering
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Interventional Imaging Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Offering
      • 9.3.3.2.2. By Application

10. Middle East and Africa Interventional Imaging Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Offering
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Interventional Imaging Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Offering
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Interventional Imaging Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Offering
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Interventional Imaging Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Offering
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Interventional Imaging Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. PESTLE Analysis

16. Pricing Analysis

17. Competitive Landscape

• 17.1. Becton, Dickinson and Company
  • 17.1.1. Business Overview
  • 17.1.2. Company Snapshot
  • 17.1.3. Products & Services
  • 17.1.4. Financials (As Reported)
  • 17.1.5. Recent Developments
• 17.2. Canon Inc.
• 17.3. Esaote SpA
• 17.4. FUJIFILM Holdings Corporation
• 17.5. Hologic, Inc.
• 17.6. Intuitive Surgical, Inc.
• 17.7. Koninklijke Philips NV
• 17.8. Medtronic plc
• 17.9. Siemens Healthineers AG
• 17.10. Stryker Corporation

18. Strategic Recommendations

19. About Us & Disclaimer